Catalog record · Operations & Efficiency
Stage as of May 21, 2026 · historical report, not live reconfirmation.
Hybrid rules and generative-AI benefit-claims assessment
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Oct 29, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
Staff mapped approximately 720 assessment rules. IBM Operational Decision Manager is assigned explicit-rule checks, while watsonx supports free-text medical certificates and consistency checks. Assessors retain final payment decisions.
- Reported stage
- Announced
- Technology
- GenAI/LLM
- Business function
- Not assessed
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 29, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Developed/announced 2026-05-21; phased operation planned from January 2027. Status as of 2026-05-21.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Documenting 720 rules shows substantial process-engineering work; human confirmation remains required. Annual 500,000-claim scope and around 40% assessor-time reduction are planned scope/benefits. It is not live as of this source. Annual 500,000-claim scope and around 40% assessor-time reduction are planned scope/benefits. It is not live as of this source.
Potential FS application · inferred
Life claims adjudication using deterministic controls around unstructured-document interpretation.
Original industry: . Transfer limits: Annual 500,000-claim scope and around 40% assessor-time reduction are planned scope/benefits. It is not live as of this source.
Source register
- Taiyo Life to fully introduce GenAI in claims assessment (Japanese)jp.newsroom.ibm.com · opens in a new tab
Taiyo Life and IBM Japan · issuer · full-text · Published 2026-05-21
Research lanes: insurance · Batch global-discovery-2026-10-29. Coverage and remaining gaps